Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypoxia Therapy in Parkinson's Disease
NCT05214287Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2022
- Primary completion
- Jul 2023
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hypoxic gas mixture in Parkinson's disease (PD) (5 arms), sponsored by Radboud University Medical Center. Primary endpoints: Nature and number of adverse events, Self-reported dizziness, discomfort and stress and 5 more. Started Feb 2022; status: completed.
02
Drugs
hypoxic gas mixture
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05214287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05214287.